Atlas Trials

Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients

Clinical trial NCT06863376 · RECRUITING

Trial details

NCT number
NCT06863376
Sponsor
Tanta University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Alcoholic Fatty Liver Disease
Start date
2025-03-01
Primary completion
2027-03-20
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.